Cancer diagnosis and prognosis using multi-Omics data: A data science and machine learning approach
1 Applied AI and Data Analytics, University of Bradford, UK.
2 Department of IT and Computer Science, University of Maryland Global Campus, USA.
3 Department of Computer Science and Information Technology, Austin Peay State University, USA.
Review Article
World Journal of Advanced Research and Reviews, 2024, 24(03), 2052-2069
Publication history:
Received on 08 November 2024; revised on 16 December 2024; accepted on 18 December 2024
Abstract:
Cancer remains one of the leading causes of morbidity and mortality worldwide, demanding innovative approaches for early diagnosis and accurate prognosis. Recent advances in multi-omics technologies, which integrate genomics, transcriptomics, proteomics, metabolomics, and epigenomics, provide comprehensive insights into the complex biological mechanisms underlying cancer. By capturing molecular signatures at multiple levels, multi-omics data offers unparalleled potential for identifying cancer biomarkers, stratifying patients, and predicting therapeutic responses. However, the volume, complexity, and heterogeneity of multi-omics data present significant analytical challenges, necessitating robust data science and machine learning techniques. Machine learning algorithms, including supervised, unsupervised, and deep learning approaches, are increasingly being utilized to unravel the patterns embedded in multi-omics datasets. These methods enable feature selection, dimensionality reduction, and the integration of multi-modal data, facilitating the identification of precise biomarkers and the development of predictive models for cancer progression. Furthermore, advanced frameworks such as explainable AI (XAI) provide interpretability to these models, ensuring their clinical applicability and enhancing trust among healthcare professionals. This review highlights recent breakthroughs in cancer diagnosis and prognosis using multi-omics data, emphasizing the synergy between data science and machine learning in transforming oncology research. It also explores the challenges in data integration, algorithmic bias, and model validation, proposing solutions to enhance predictive accuracy and generalizability. By bridging molecular biology and computational sciences, this interdisciplinary approach has the potential to revolutionize precision oncology, paving the way for personalized treatment strategies and improved patient outcomes.
Keywords:
Cancer Diagnosis; Multi-Omics Data; Machine Learning; Data Science; Precision Oncology; Biomarker Discovery
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0